Almac Clinical Technologies, part of Almac Group, has published a report, which finds that the use of an automated chain-of-custody system can save a minimum of $1,300,000 per clinical trial in operating costs.   The drug accountability and reconciliation processes are noted for being time-consuming and error-prone, two characteristics that result in contributing to clinical trial costs and timelines. The task of reconciling discrepancies in drug supply records, which can accumulate over the cou...